Distinguished in Hemorrhagic Proctocolitis

Par E. Myrelid

Linkoeping, E, SE 
Distinguished in Hemorrhagic Proctocolitis
Linkoeping, E, SE 
OverviewLocationsClinical Research

Overview

Par Myrelid practices in Linkoeping, Sweden. Ms. Myrelid is rated as a Distinguished expert by MediFind in the treatment of Hemorrhagic Proctocolitis. Her top areas of expertise are Viral Gastroenteritis, Colitis, Ulcerative Colitis, Ileostomy, and Appendectomy.

Her clinical research consists of co-authoring 118 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 42 articles in the study of Hemorrhagic Proctocolitis.

Gender
Female

Locations

Linkoeping, E, Sweden
Other Locations
Stockholm, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3

116 Total Publications

Editorial: Resecting Assumptions-Do Proctocolectomy Guidelines Hold Up? Author's Reply.
Editorial: Resecting Assumptions-Do Proctocolectomy Guidelines Hold Up? Author's Reply.
Journal: Alimentary pharmacology & therapeutics
Published: August 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Myrelid's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile